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Cancer is a disease that requires a multidisciplinary approach
toﬁghtit.Thestudyofspeciﬁcmutationsisnolongersufﬁcient
to explain the onset of complex pathologies including cancer,
diabetes or neurodegenerative diseases. This observation
urges to integrate various omics technologies in order to
unravel novel regulatory networks allowing to better under-
standing the development of these diseases. The merge of
high-throughput screening techniques (genomics, transcrip-
tomics, proteomics and metabolomics) with other disciplines
including mathematics, bioinformatics and systems biology
will allow the discovery of fundamental insights that would
remain obscure otherwise. This interdisciplinary approach
thus permits to better understand and interpret complex
biological phenomena by taking into consideration multiple
parameters. Results can then be conﬁrmed by various
techniques strengthening the importance of the interdisciplin-
ary OMICS.
Inthiscontext,the‘CellSignal-omics2011’conferencetook
place last January (26–28) in Luxembourg. This congress,
focusing on ‘Integrated cellular pathology and Systems
Biology of human disease’, gathered together more than
350 international scientists implicated in the different
branches of OMICS at the European Congress Center in
Luxembourg.
The opening keynote session was given by Professor Mario
Capecchi, molecular geneticist and 2007 Nobel Prize winner
in Physiology or Medicine, for discovering a method introdu-
cing homologous recombination in mice by employing
embryonic stem cells. Professor Capecchi presented the
importance of gene targeting in mouse models of various
human diseases, including cancer and neuropsychiatric
disorders. He underlined the fact that synovial sarcoma mouse
models expressing the chimeric SYT–SSX2 fusion protein were
useful to identify the skeletal muscle lineage as a source of
synovial sarcoma. In the case of neuropsychiatric disorders
he pointed out the hematopoietic origin of pathological
grooming in Hoxb8 mutant mice by explaining that Hoxb8-
cell lineage exclusively labels bone marrow-derived microglia
and that disruption of Hoxb8 in the hematopoietic system
recapitulates the obsessive-grooming behavior disorder.
The importance of gene targeting was reinforced by several
discussionsdedicatedtotheroleofgeneexpressionnetworks
in health and disease. As presented by Dr. Franc ¸ois Fuks
(Free University of Brussels, Belgium), cellular transformation
and malignant evolution are connected to gene expression
and silencing mediated by epigenetics perturbations, such as
histone modiﬁcations and DNA methylation mediated by DNA
methyltransferases, thus leading to aberrant chromatin
dynamic. According to Fuks, DNA methylation proﬁling
appeared as a potent tool to characterize cancer tissues
and to optimize personalized medicine. In addition, a large
panel of promising molecules exhibiting histone de-acetylase
inhibitory activity is under investigation for the development
of new anticancer therapies as reported by Dr. Michael
Bots (Peter MacCallum Cancer Centre, Victoria, Australia).
Dr. Luciano Di Croce’s team from the CRG/ICREA in Barcelona,
Spain identiﬁed a protein complex of ZRF1/histone mutant
macroH2A that is involved in the establishment and main-
tenance of the abnormal silencing of tumor suppressor genes
during transformation.
Furthermore, Professor Guido Kroemer (IGR, Paris, France)
highlighted the importance of autophagy-regulatory networks
represented by acetylases and de-acetylases, and discussed
an interconnection between autophagy and life span. Both
types of autophagy-inducing pharmacological agents, SIRT1-
dependent (resveratrol) as well as SIRT1-independent
(spermidine), extend longevity in an autophagy-dependent
manner. Hence, autophagy promotes mostly cytoprotective
ratherthancytotoxiceffects.Thepharmacologicaltargetingof
control points of the autophagy system by combining
established cancer treatments with autophagy inhibitors such
as Atg5/7 silencing or hydroxychloroquine was presented
by Professor Eileen White of Rutgers University (NJ, USA).
The emerging understanding of the role of autophagy in
common resistance to chemotherapy leads to the develop-
ment of therapeutic strategies that target cell death pathways.
Nevertheless, the balance between activation of cell death in
cancer cells and protection of healthy tissue remains a
concern. In that sense, the impact of cell death of oocytes in
healthy and chemotherapeutic agent-treated women was
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The oocytes competence was shown to be age-related.
A proteomic approach presented by Cinzia Di Pietro
(University of Catania, Italy) pointed out that 40 genes are
differentially expressed between old (women438 years old)
and young (womeno32 years old) oocytes with an upregula-
tion of pro-apoptotic genes including TAp73 and caspases
and downregulation of anti-apoptotic (Bcl-2, Mcl-1, NF-kB)
genes in old oocytes. As explained by Dr. Stefania Gonﬂoni
(University of Rome Tor Vergata and LBMCC, Luxembourg),
germ cells are sensitive to genotoxins and oocytes of women
treated with chemotherapeutic agents are massively degraded.
This type of cell death is the cause of infertility and could
be explained by TAp63 accumulation in early post-natal
oocytes and by p63-dependent activation of pro-apoptotic
promoters. Gonﬂoni hypothetized that cisplatin-induced side
effects could be neutralized by a pre-treatment with the
Bcr–abl inhibitor Imatinib that is able to protect oocytes from
cisplatin treatment in modulation of p63 transcription through
its c-Abl kinase inhibitor activity. Professor Gerry Melino also
from Tro Vergata (Rome, Italy) also underlined the important
implication of p53 family members as guardians of maternal
reproduction and their impact at the evolutionary level. He
presented the novel involvement of p73 in neuronal develop-
ment and the role of TAp73 as a driver of miR-34a; its
expression contributes to the commitment of embryonic stem
cells in neurons and modulates the expression of speciﬁc
synaptic genes.
This is in line with Professor Capecchi and other groups
who underlined the importance of stem cell line models.
Ninety percent of cancer mortality is due to therapy resistance
and metastasis. The fatal evolution of the disease suggests
thepresenceofcancerstemcellsthatsurvivebecauseoftheir
embryonic or pluripotent characteristics. During the meeting
Dr. Anne Grosse-Wilde (ISB, Seattle, WA, USA) highlighted
the importance of the identiﬁcation and the in-depth charac-
terization of such cells.
Nowadays, systems biology becomes essential in various
disciplines of life sciences and reaches researchers progres-
sively. As emphasized by Professor Antonio del Sol (ISBM,
Luxembourg), molecular therapeutic strategies could beneﬁt
from a better understanding of disease-related network
perturbations that could be highlighted by the analysis of
cellular network components. Dr. Nicolai Lavrik (DKFZ,
Heidelberg, Germany) focused on the importance of systems
biology to understand the regulation and balance between
life and death in CD95 system. This integrated concept
allowed the identiﬁcation of novel mechanisms of regulation
of CD95 signaling as well as the ratio pro/anti-apoptotic
death effector domain-containing proteins requested to
determine the decision between life and death by describing
the complex dynamics of CD95-mediated apoptosis and
NF-kB signaling. In addition, Professor Jacques Piette’s group
at the ULg in Lie `ge, Belgium pointed out the importance
of CD95-glycosylation mediated by the anti-apoptotic role
of SHIP-1 in order to reduce T-cell death by apoptosis.
His attention was directed to search for novel SHIP-1
interaction partners. Interestingly, this team identiﬁed
interactions between SHIP-1 and two IAP family members
(cIAP-1 and XIAP).
Interplay between immunity, cell death and chronic viral
infection was underlined by Professor Marie-Lise Gougeon
(Pasteur Institute, Paris, France) on the basis of an HIV-
infected dendritic cell model. The main role seems to be
played by cross talks between dendritic cells and autologous
natural killer (NK) cells. NK cells are usually responsible for
the elimination of infected dendritic cells and this process is
believed to be an essential step for early control of viral
replication and dissemination. Interestingly, Gougeon’s team
discovered that upon HIV infection, dendritic cells become
resistant to NK-dependent lysis. Moreover, they showed that
NK interaction with dendritic cells triggered apoptosis resis-
tanceowing to dramatic upregulation of two major inhibitors of
apoptosis cIAP-2 and c-FLIP and thus contributing to the
constitution of long-term viral reservoirs. Identiﬁcation of
the essential role of HMGB1 in this signaling chain provided
a novel therapeutic target to eliminate viral reservoirs.
Dr. Andrew Koff (Memorial Sloan–Kettering Cancer Center,
NY, USA) has presented a new insight into the usage of the
cdk inhibitor p27 as a biomarker in human cancer prognosis.
He elaborated a bioinformatic approach to test the relation-
ship between SV40 small t-antigen and oncogenes. Through
in silico pathway analysis, they showed a negative correla-
tion between expression of SV40 small t-antigen and p27
accumulation. Finally, the developed network identiﬁed p27
levels as a witness of the activation of oncogenic signaling
pathways and as a valuable trait of cancer prognosis. The
immune system is a complex machinery strictly dependent
on homeostatic control. The GTPase immunity associated
protein 5 (Gimap5) has been previously identiﬁed as a mediator
of immune homeostasis. Professor Kasper Hoebe (Cincinnati
Children’sHospitalResearchFoundation,Cincinnati,OH,USA)
pointed out the role of this protein as a key regulator of hemato-
poietic integrity and as a critical mediator of lymphocyte homeo-
stasis. Hoebe’s team focused on a recessive ENU-induced
germline mutation destabilizing Gimap5 and leading to
lymphopenia, hepatic extramedullary hematopoiesis, weight
loss and intestinal inﬂammation in homozygote mutant mice.
Besides previously mentionedpopulation diseases,several
talks focused on obesity and neurodegenerative diseases.
Differential risk of metabolic syndrome between central and
peripheral obesity was investigated by the team of Professor
Yong Sang Song (Seoul National University, South Korea).
According to Song, more than 500 genes related to energy
metabolism showed differential expression patterns in human
subcutaneous versus human visceral adipose-derived stem
cells. Observed differences could be responsible for the
important involvement of central obesity in metabolic syn-
drome. At the present time, much attention is also dedicated
to neurodegenerative diseases. In case of Alzheimer’s
disease, Dr. Xin-Fu Zhou (Flinders University, Adelaide,
South Australia) presented data supporting that the neuro-
tropin receptor, p75NTR, has a critical role in regulating
amyloid-beta levels by both increasing amyloid-beta produc-
tion and attenuating its aggregation in the cerebral cortex
and hippocampus. Moreover, Professor Vittorio Calabrese
(University of Catania, Italy) pointed out the importance of
vitagenes, metabolic stress, hormesis and of the modulation
of endogenous cellular pathways. The interplay between
metabolism, mitochondrial energetics and activation of critical
Meeting Report
2
Cell Death and Diseasevitagene cascades should be included in order to confer
protection against chronic degenerative damage associated to
aging and neurodegenerative disorders. He also showed that
the induction of hormetic pathways by dietary antioxidants
compounds confer them an interesting neuroprotective poten-
tial. Other strategies to ﬁght neuronal disorders were presented
by Dr. Mark Mattson (National Institute on Aging, Baltimore, MD,
USA). He underlined the impact of dietary energy intake as well
as sedentary lifestyle and drugs, (e.g. plumbagin) as activators
of adaptive stress response pathways, on cognitive aging.
Altogether, this excellently organized meeting provided a
detailed insight into one of the most exciting scientiﬁc ﬁelds
moving rapidly. Congratulations to the organizers!
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Next meetings
Phytochemicals and compounds from natural origins are
nowadays under investigation for their therapeutic and
medicinal potential role on human health and diseases. The
last ﬁndings of worldwide research on this topic will be
presented during our next meetings:
Redox regulation – Natural compounds as regulators of
inﬂammation signaling
(RedCat satellite meeting to Natural Compounds 2012)
25–27 January 2012
Under the patronage of Corena, a network aiming to create
an internationally competitive cluster within the Greater
Region (Saarland, Lorraine, Luxembourg, Wallonia, Rhein-
land-Pfalz). Corena is co-funded by European Regional
development fund within the INTERREG IVA Greater Region
program. The European Union invests in your future.
Meeting information: http://www.transduction-meeting.lu
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